Tag: Diagnostics

Pandemic Patients main logo.

FDA Authorizes the InspectIR COVID-19 Breathalyzer

On April 14, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to the InspectIR COVID-19 Breathalyzer test. This new diagnostic tool uses a technique called gas chromatography gas mass-spectrometry (GC-MS) to identify whether the SARS-CoV-2 virus is present in a person’s breath.

Continue Reading...